Skip to main content
GENINCODE PLC logo

GENINCODE PLC — Investor Relations & Filings

Ticker · GENI ISIN · GB00BL97B504 LEI · 213800UX6TE7K65O2892 IL Professional, scientific and technical activities
Open in API
Filings indexed 112 across all filing types
Latest filing 2026-05-07 Director's Dealing
Country GB United Kingdom
Listing IL GENI

About GENINCODE PLC

https://genincode.com/

GENINCODE PLC specializes in the genetic risk assessment and prediction of cardiovascular disease (CVD). The company develops and commercializes clinical genetic tests that combine genomic data with clinical algorithms and artificial intelligence (AI). These advanced risk assessment tools provide physicians with a predictive analysis of a patient's health, enabling personalized prevention and treatment strategies for CVD. The company's technology is founded on over 15 years of research and development in cardiovascular genomics, aiming to improve patient outcomes by identifying at-risk individuals before the onset of disease.

Recent filings

Filing Released Lang Actions
Grant of Share Options & PDMR Dealings
Director's Dealing
2026-05-07 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by GENinCode PLC. It details the acquisition or disposal of voting rights by First Equity Limited and Armstrong Investments Limited, specifically noting a change in shareholding percentage. This is a standard regulatory disclosure for major shareholding notifications, which corresponds to the 'Major Shareholding Notification' category.
2026-02-26 English
Holding(s) in Company
Regulatory Filings
2026-02-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by GENinCode PLC. It details a change in voting rights held by Octopus Investments Limited, specifically noting that the threshold was crossed on 11-Feb-2026. This is a standard regulatory disclosure for major shareholding notifications, which corresponds to the MRQ category.
2026-02-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by GENinCode PLC. It details an acquisition of voting rights by First Equity Limited, crossing the threshold of 5.31%. This is a standard regulatory disclosure for major shareholding notifications, which corresponds to the 'Major Shareholding Notification' category.
2026-02-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by GENinCode PLC. It explicitly details an acquisition or disposal of voting rights by Maven Capital Partners UK LLP, crossing a specific threshold. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2026-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.